Venrock Healthcare Capital Partners II L.P. 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:19 pm Purchase |
2021-03-26 | 13G | Relmada Therapeutics, Inc. RLMD |
Venrock Healthcare Capital Partners II L.P. | 2,270,072 8.200% |
1,601,632 (+239.61%) |
Filing |
| 2021-02-16 4:10 pm Sale |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Venrock Healthcare Capital Partners II L.P. | 668,440 4.100% |
-214,374 (-24.28%) |
Filing |